Sports
CervoMed Completes Enrollment In Phase 2a Study Of Neflamapimod For Nfv.Primary Progressive Aphasia
(RTTNews) - CervoMed Inc. (CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders, announced that it has completed enrollment in the Phase 2a study of its lead investigationa…